| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jun―12 |
The Dynamics of SARS-CoV-2 Virus Infection, Effectiveness of Vaccination and Revaccination with Sputnik V and Sputnik Light Drugs for Non-Specialized Medical Workers during the COVID-19 Pandemic |
V. I. Kiseleva, I. A. Zamulaeva, N. M. Lipunov, L. V. Lyubina, G. P. Bezyaeva, L. V. Panarina, et al. (+7) I. L. Ershova, T. A. Agababyan, N. K. Silant’eva, N. V. Severskaya, V. A. Petrov, S. A. Ivanov, A. D. Kaprin |
| 2 |
[GO] |
2026―Apr―01 |
Is the H5N1 Avian Influenza Virus a Herald of a New Influenza Pandemic? |
E. P. Kharchenko |
| 3 |
[GO] |
2026―Apr―01 |
Cross-Neutralizing Activity of a Live Intranasal Vaccine Based on the Recombinant Sendai Virus of the Moscow Strain against Different Variants of SARS-CoV-2 |
G. A. Kudrov, S. S. Zainutdinov, A. V. Zaykovskaya, I. S. Shulgina, A. A. Grazhdantseva, G. F. Sivolobova, et al. (+3) S. A. Bodnev, A. A. Sergeev, G. V. Kochneva |
| 4 |
[GO] |
2026―Apr―01 |
Polymorphic Variants of IL23R, IL6, IL28B, IL17F Genes in Patients Who Have Survived after Coronavirus SARS-CoV-2 Infection |
A. L. Klass, E. V. Filatova, S. B. Kalnova, S. V. Rustamova, M. I. Shadrina, P. A. Slominsky |
| 5 |
[GO] |
2026―Apr―01 |
Coronaviruses in Human Pathophysiology: a Brief History of the COVID-19 Pandemic |
I. N. Vlasov, M. I. Shadrina, P. A. Slominskii |
| 6 |
[GO] |
2025―Sep―22 |
Angiotensin-Converting Enzyme 2 (ACE2) and the Transmembrane Protease Serine 2 (TMPRSS2): Biomarkers for Predicting COVID-19 Disease Severity |
Behrouz Farzanegan, Naghmeh Bahrami, Maryam Akhtari, Mohammad Fathi, Saba Tahmasebi, Mehdi Kazem pour Dizaji, et al. (+3) Shadi Shafaghi, Maryam Hajimoradi, Abdolreza Mohamadnia |
| 7 |
[GO] |
2025―Mar―15 |
A Review of COVID-19 Effective Pharmaceutics Based on Molecular Targets and Single Nucleotide Polymorphisms |
Saba Seyedi, Mohammadreza Gerami, Shadan Navid, Samira Ezi, Ziba Nariman-Saleh-Fam, Lida Nariman-Saleh-Fam, Zahra Saadatian |
| 8 |
[GO] |
2025―Jan―10 |
The Impact of COVID-19 Infection on Lung Cancer Stem Cells and Photodynamic Therapy as a Potential Way to Combat Both Pathologies |
E. A. Kogan, G. A. Meerovich, S. T. Avraamova, I. D. Romanishkin, E. E. Shchelokova, E. V. Akhlyustina, et al. (+4) A. I. Mordovina, S. A. Demura, Z.-L. Chen, I. V. Reshetov |
| 9 |
[GO] |
2025―Jan―10 |
Dynamics of the Spectrum of Genotypes in Listeria monocytogenes, Which Caused Invasive Listeriosis during the Circulation of SARS-CoV-2 Omicron Variants |
O. L. Voronina, N. N. Ryzhova, M. S. Kunda, E. I. Ermolova, E. R. Goncharova, M. S. Samarina, et al. (+5) M. A. Kustova, T. I. Karpova, E. A. Klimova, A. R. Melkumyan, I. S. Tartakovsky |
| 10 |
[GO] |
2024―Oct―25 |
SARS-CoV-2 Related miRNAs and Their Potential Role in Combating Severe COVID-19 |
Guihao Li, Xiaopei Huang, Jun Yang |
| 11 |
[GO] |
2024―Jul―09 |
Critical Point Mutations in the RBD of SARS-COV-2 Involved in Binding to ACE2 |
Safar Farajnia, Davoud Farajzadeh, Leila Rahbarnia, Ali Rabbizadeh Saray |
| 12 |
[GO] |
2024―Mar―20 |
Comparative Analysis of Influenza Viruses Isolated from Early and Severe Cases in Epidemic Seasons before and during the COVID-19 Pandemic in Russia (2019-2023) |
N. D. Boldyrev, A. S. Panova, N. P. Kolosova, A. V. Danilenko, S. V. Svyatchenko, G. S. Onkhonova, et al. (+2) V. Yu. Marchenko, A. B. Ryzhikov |
| 13 |
[GO] |
2024―Mar―20 |
Monitoring the Spread of SARS-CoV-2 Gene Variants in Sverdlovsk and Chelyabinsk Oblasts and Perm Krai |
A. E. Chernysheva, I. A. Korotkova, E. V. Bolgarova, A. Yu. Markaryan, A. V. Semenov |
| 14 |
[GO] |
2024―Jan―13 |
Genetic Variations in Spike Protein: Linking SARS-CoV-2 Variants to Clinical Outcomes |
Peshnyar M. A. Rashid, Gaza F. Salih |
| 15 |
[GO] |
2023―Sep―11 |
RNA N6-Methyladenosine Pathway Writer Genes Expression Levels and Clinical Severity of Infection in Covid-19 Patients |
Badel Arslan, Sevgi Baltacı, Burcu Bayyurt, Nil Özbilum Sahin, Murat Eser Akyurek, Mehmet Bakır, Serdal Arslan |
| 16 |
[GO] |
2023―Sep―11 |
LZTFL1 rs17713054 Polymorphism as an Indicator Allele for COVID-19 Severity |
Mona Roozbehani, Hossein Keyvani, MohammadHossein Razizadeh, Parastoo Yousefi, Ali Gholami, Alireza Tabibzadeh, Leila Mousavizadeh |
| 17 |
[GO] |
2023―Sep―11 |
Recombinant RBD of the SARS-CoV-2 Spike Protein: Production in Escherichia coli Cells, Binding to Antibodies, and Antiviral Activity |
M. S. Gromova, A. V. Gromov, T. M. Grunina, A. M. Lyashchuk, Z. M. Galushkina, M. E. Subbotina, et al. (+8) I. B. Esmagambetov, E. I. Ryabova, V. V. Prokofiev, A. V. Kovyrshina, A. A. Ilyukhina, A. Y. Shelkov, A. S. Karyagina, V. G. Lunin |
| 18 |
[GO] |
2023―Mar―20 |
Comparison of Fragments in Human Hemostatic Proteins That Mimics Fragments in Proteins of A/H1N1 Viruses and Coronaviruses |
I. N. Zhilinskaya, V. A. Marchenko, E. P. Kharchenko |
| 19 |
[GO] |
2022―Dec―25 |
COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part 2. Other Acute Respiratory Viral Infections |
T. N. Ilyicheva, S. V. Netesov, V. N. Gureyev |
| 20 |
[GO] |
2022―Dec―25 |
Oral Delivery of SARS-CoV-2 DNA Vaccines Using Attenuated Salmonella typhimurium as a Carrier in Rat |
Dan Zhu, Mengyue Mengyue, Aaodeng Qimuge, Bilige Bilige, Tegexi Baiyin, Temuqile Temuqile, et al. (+4) Shana Chen, Siqin Borjigen, Huricha Baigude, Dezhi Yang |
| 21 |
[GO] |
2022―Aug―01 |
COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza |
T. N. Ilyicheva, S. V. Netesov, V. N. Gureyev |
| 22 |
[GO] |
2021―Sep―10 |
Variability of the Genome of El Tor Cholera Vibrios Isolated before the Onset and in Different Periods of the Current Pandemic |
N. I. Smirnova, D. V. Badanin, D. A. Rybal’chenko, Ya. M. Krasnov, A. A. Kritsky, Yu. V. Lozovsky, et al. (+2) A. V. Fedorov, V. V. Kutyrev |
| 23 |
[GO] |
2021―Jun―03 |
SARS-CoV-2 and Patent Activity |
I. B. Nikitina, E. A. Smirnova |
| 24 |
[GO] |
2020―Sep―10 |
The New Coronavirus COVID-19 Infection |
M. R. Bevova, S. V. Netesov, Yu. S. Aulchenko |
|
